0001437749-15-005862.txt : 20150323
0001437749-15-005862.hdr.sgml : 20150323
20150323201725
ACCESSION NUMBER: 0001437749-15-005862
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150319
FILED AS OF DATE: 20150323
DATE AS OF CHANGE: 20150323
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RESPONSE BIOMEDICAL CORP
CENTRAL INDEX KEY: 0000806888
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1781 - 75TH AVENUE W.
CITY: VANCOUVER
STATE: A1
ZIP: V6P6P2
BUSINESS PHONE: 604-456-6010
MAIL ADDRESS:
STREET 1: 1781 - 75TH AVENUE W.
CITY: VANCOUVER
STATE: A1
ZIP: V6P6P2
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shuster Lewis
CENTRAL INDEX KEY: 0001471131
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50571
FILM NUMBER: 15720278
MAIL ADDRESS:
STREET 1: 421 BRIDOON TERRACE
CITY: ENCINITAS
STATE: CA
ZIP: 92024
4
1
rdgdoc.xml
FORM 4
X0306
4
2015-03-19
0000806888
RESPONSE BIOMEDICAL CORP
RBM
0001471131
Shuster Lewis
1781 - 75TH AVENUE W.
VANCOUVER
A1
V6P 6P2
BRITISH COLUMBIA, CANADA
1
Common Stock
2015-03-19
4
A
0
9510
0
D
57852
D
Stock Option (Right to Buy)
0.92
2015-03-19
4
A
0
5000
0
A
2025-03-19
Common Stock
5000
5000
D
100% of the restricted share units vested on the date of grant. The expiration date for each of the restricted share units will be the earlier of three (3) years after the effective date or two (2) years following the grantee's termination date. The reporting person has elected to defer receipt of the common stock underlying the restricted share units until a later date not to exceed the expiration date.
Exercise prices shown are denominated in Canadian dollars.
100% of the options vest on March 20, 2016, subject to the reporting person's continued service as a director of the Company through each vesting date.
/s/ Anastasios Tsonis, Attorney in Fact
2015-03-23